HAEMONETICS CORPORATION (HAE) Operating margin 2017–2026
HAEMONETICS CORPORATION (HAE) operating margin by fiscal year — reported operating income divided by reported revenue.
11.7%FY2026 · since FY2017: -2.2% → 11.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 11.7% | -4.6 pp |
| FY2025 | 16.3% | +3.7 pp |
| FY2024 | 12.6% | -0.8 pp |
| FY2023 | 13.4% | +5.2 pp |
| FY2022 | 8.1% | -2.2 pp |
| FY2021 | 10.3% | -0.1 pp |
| FY2020 | 10.5% | +1.8 pp |
| FY2019 | 8.6% | +2.4 pp |
| FY2018 | 6.2% | +8.4 pp |
| FY2017 | -2.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice